Guardant Health (GH) Asset Writedowns and Impairment (2022 - 2025)

Guardant Health (GH) posted Asset Writedowns and Impairment of $13.6 million for Q4 2025, up 171.64% sequentially from $5.0 million in Q1 2025.

Guardant Health (GH) Asset Writedowns and Impairment (2022 - 2025) Analysis & Trends

Guardant Health has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $13.6 million in Q4 2025.

Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $13.6 million in Q4 2025, while the trailing twelve-month figure through Jun 2026 was $13.6 million (up 171.64% YoY) and the FY2025 annual result came in at $18.6 million, changed N/A from the prior year.
Asset Writedowns and Impairment advanced to $13.6 million in Q4 2025 per GH's latest filing, from $5.0 million in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $23.6 million in Q2 2023 and troughed at $5.0 million in Q1 2025.
A 3-year average of $10.6 million and a median of $5.5 million in 2023 frame the typical range for Asset Writedowns and Impairment.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	Guardant Health	22.38 Bn	21.33 Bn	219.03 Mn

Download Data